Last Update 14 Aug 26
Fair value Decreased 3.89%SIPEF revisited on H1 2026 data — a three-model methodology read
116,29 Eur : One model's answer — the discounted cash flow — to what SIPEF is worth. Not a target, not a promise: a mechanical output of assumptions you can see, challenge, and rerun yourself.
And it leans on one big IF.
SIPEF just posted a record half-year: revenue up 23 %, another record year guided. Every reading below assumes generous palm-oil economics persist — run the models at mid-cycle instead and the picture changes sharply; the residual income model falls below book value. A potentially severe El Niño is developing, and even that cuts both ways: it could take SIPEF's volumes down and palm prices up.
Three models, three honest answers: DCF €95,69 · residual income €91,08 · dividend discount €45,13. No blended number, no verdict — the disagreement is published, not averaged. Which world SIPEF lives in is a palm-oil judgement, and the full article hands you the grids to make it yourself.
The fair value shown on this narrative is ONE model's reading: the discounted cash flow model at mid level €95,69. It is not a consolidated fair value. The full article runs three intrinsic models on identical shared inputs and publishes them side by side, with honest disagreement:
· DCF €95,69 (envelope €82,43–€116,29)
· Residual income €91,08 (envelope €83,89–€98,82)
· Dividend discount €45,13 (envelope €38,21–€55,88)
Confluence Zone reporting is suspended pending methodology v2 — where model envelopes overlap, that overlap is not reported as corroboration, which is why no combined figure appears here.
The construction, briefly: a 10,58 % discount rate (3,18 % risk-free, 10-year German Bund, 13 August 2026; 5,00 % equity risk premium; 2,40 % country-risk premium for Indonesia/PNG); a 25,0 % mid-cycle EBIT margin held deliberately below the first half's roughly 30,8 % and 2025's 32,9 %, because the assumption values the middle of the palm-oil cycle, not the top; every USD figure divided by 1,15 exactly (operator spot, 13 August 2026); price at the analysis date €97,00, intraday, 13 August 2026.
The caveat that matters more than any reading: the residual income model leans on 2025's peak 12,5 % return on equity persisting. At a mid-cycle return near 9,9 %, its reading falls below the €84,17 book value. The article's sensitivity grids show every step of that slide — and the calculators on the site are free if you want to rerun any model with your own assumptions.
Full article — every input tagged fact or assumption, every grid:
Strong Operational Momentum
- Palm oil production up +19.1% YoY, driven by improved yields and extraction rates.
- Banana volumes up +3.4%, supported by maturing plantations.
- Oil extraction rate improved by 1.1%, enhancing efficiency.
Robust Financial Performance
- Revenue up +25% YoY.
- Net profit surged +131% YoY to USD 57.7M.
- Free cash flow more than doubled, supporting future growth and dividends.
- Net cash position of USD 19.9M, indicating strong balance sheet health.
Favorable Market Dynamics
- CPO prices rose to USD 965/tonne, up 15.3% YoY.
- B50 biofuel mandate in Indonesia and global biofuel trends expected to boost demand and support pricing.
Sustainability & Innovation
- Continued investment in biogas, CNG, and hybrid seed development.
- Expansion of RSPO certification to smallholders enhances ESG appeal.
Risks to Monitor
- Geopolitical and tariff risks in Indonesia.
- Weather volatility, especially drought in Northern Sumatra and Bengkulu.
- Input cost pressures (fertilizer, fuel, labor), though currently stable.
Valuation Snapshot
- Graham Valuation fair value 102
- DCF Valuation fair value 107
- Multiples Valuation fair value 114
- Weighted Average fair value 115
Current market price offers upside potential to fair value of €115/share.
My conclusion
SIPEF combines strong fundamentals, sustainable growth, and exposure to rising biofuel demand. With improving margins, a healthy balance sheet, and a clear ESG strategy, SIPEF is well-positioned to deliver long-term value.
Have other thoughts on Sipef?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Comments
0 commentsDisclaimer
The user StoxEurope has a position in ENXTBR:SIP. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.